Do We Have to Obtain Rebound Bilirubin Levels and What is the Optimal Time?

Journal Title: The Journal of Pediatric Research - Year 2019, Vol 6, Issue 1

Abstract

Aim: We aimed to determine the frequency of rebound hyperbilirubinemia (RHB) needing treatment and therefrom, to clarify the clinical importance of routinely checking serum total bilirubin (STB) levels after the cessation of phototherapy and to define an optimal time to check STB levels for the detection of RHB. Materials and Methods: Term and late preterm babies who received phototherapy were included in this study. The demographic and clinical features, time of onset of jaundice, phototherapy time and results to determine the etiology of jaundice were recorded for all babies. Serum “rebound” bilirubin measurements were performed two times at 12 and at 24 hours after the cessation of phototherapy. The re-initiation of phototherapy according to the 12th and 24th hour STB levels was accepted as “early rebound” and “late rebound”, respectively. IBM SPSS 22 was used for statistical analyses. Results: Data was available for 110 infants. The rebound rate requiring phototherapy was 9.1% (n=10) and all had a risk factor. Most of the babies (9/10) rebounded at the 12th hour after the termination of phototherapy. Hemolysis and prematurity were found to be statistically significant for RHB (p=0.008; p=0.048). Conclusion: Post-phototherapy bilirubin follow-up may be incorporated using a combined approach of individualization, evaluation of risk factors, and application of common sense before discharge. Our study showed that STB levels could be measured after the cessation of phototherapy, especially in patients with a risk factor, at the 12th hour before discharge. Randomized controlled studies with larger sample sizes are still needed for definitive recommendations.

Authors and Affiliations

Hülya Özdemir, Hülya Selva Bilgen, Aslı Memişoğlu, Zeynep Alp Ünkar, Ali Mutlu, Eren Özek

Keywords

Related Articles

Results of Vincristine, Cyclophosphamide and Topotecan Protocol in Refractory/Relapsed Pediatric Solid Tumors: A Single-center Experience

Aim: Despite dramatic progress in the treatment of pediatric solid tumors in the last 3 decades, confronting a relapsed or refractory patient is still challenging. We report our experience of refractory/relapsed pediatri...

Substance Use Among Adolescents, and Influencing Factors in Şanlıurfa

Aim: The aim of this study was to investigate substance use by students in the 7-12th grades. Materials and Methods: The research was conducted as a descriptive study in Şanlıurfa, which has a very young population, betw...

Determination of Perceived Social Support and Burnout Levels of Mothers of Children with Intellectual Disability

Aim: The aim of this study is to determine the correlation between the perceived social support and burnout levels of the mothers of intellectually disabled (ID) children and the affecting factors. Materials and Methods:...

Familial Mediterranean Fever Mimicking Wilson’s Disease: A Case Report

Wilson’s disease (hepatolenticular degeneration) is an autosomal recessive defect in cellular copper transport. Impaired biliary copper excretion leads to an accumulation of copper mostly in the liver, brain and cornea....

Evaluation of the Frequency of Obesity and Associated Factors in Children of Obese and Overweight Mothers

Aim: The mother is an important determinant of the nutrition of her children. The aim of this study is to evaluate the relationship between obese or overweight mothers, their socio-demographic status and appetite on the...

Download PDF file
  • EP ID EP549472
  • DOI 10.4274/jpr.galenos.2019.03064
  • Views 93
  • Downloads 0

How To Cite

Hülya Özdemir, Hülya Selva Bilgen, Aslı Memişoğlu, Zeynep Alp Ünkar, Ali Mutlu, Eren Özek (2019). Do We Have to Obtain Rebound Bilirubin Levels and What is the Optimal Time?. The Journal of Pediatric Research, 6(1), 7-11. https://europub.co.uk/articles/-A-549472